• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • Other News

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

Summary Of China Standards Of 9706 Series Effective Since May 1, 2023

2023-07-19

China standards of 9706 series have been effective since May 1, 2023. The summary is shown as below.…

NMPA Suspended The Import, Sales And Use Of ExFuse Bone Graft Of HansBiomed Corp. After Remote QMS Audit

2023-07-17

National Medical Products Administration (NMPA) organized a remote QMS inspection of the ExFuse Bone Graft manufactured by HansBiomed…

China NMPA Newsletter – May 2023

2023-07-14

Featured Articles NMPA New Approvals in May 2023 In May 2023, NMPA approved 175 medical devices, including 27…

China NMPA Approves Innovative Head And Neck X-ray Stereotactic Radiosurgery System For Market

2023-06-27

On June 20, 2023, NMPA approved for the registration application of the cutting-edge medical device, the "Head and…

NMPA New Approvals In May 2023

2023-06-25

In May 2023, NMPA approved 175 medical devices, including 27 Class III imported products, 20 Class II imported…

China Releases Detailed Implementation Rules For Managing Human Genetic Resources

2023-06-25

On June 1, 2023, the Ministry of Science and Technology of China has announced the issuance of the…

NMPA Notice On The On-Site Inspection Guidelines Of Enterprise Quality Management Specialized In Medical Device Transportation And Storage Services As Appendix For Medical Device Good Supply Practice

2023-06-06

On May 24, 2023, NMPA releases new guidelines aimed at enhancing the supervision and management of medical device…

China NMPA Newsletter – April 2023

2023-06-01

Featured Articles NMPA New Approvals in April 2023 In March 2023, NMPA approved 290 medical devices, including 33…

NMPA New Plans On 118 Medical Device Registration Guidelines In 2023

2023-05-29

On April 4, NMPA releases the new plan for medical device registration guidelines in 2023 (NMPA, No. 6…

NMPA Further Enhancing The Surveillance On Radiofrequency Beauty Devices

2023-05-29

On April 12, the NMPA published Announcement No. 8 of 2023, which outlined the "Guidelines for Registration Review…

NMPA New Policy To Support China Real World Study

2023-05-29

On April 25, 2023, NMPA CMDE, Hainan local NMPA, and Hainan Boao Lecheng International Medical Tourism Pilot Zone…

NMPA New Approvals In April 2023

2023-05-22

In April 2023, NMPA approved 180 medical devices, including 21 Class III imported products, 33 Class II imported…
« Prev...45678...121416...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7